microdosing glp-1 dosage GLP-1's for Weight Loss & Inflamation:-Dr Lipman, Miami GLP-1 microdosing is experimental and

Obesity and the kidney: mechanistic links and therapeutic advances

Obesity 32 , 232233 (2024)

While severe malabsorption is not common with GLP-1 RAs, these factors combined with lower intake could contribute to deficiencies over time

BMI measurements are counted at the start of GLP-1 therapy, so even people who fall below the threshold now can qualify if they can show they had a high enough BMI when they began taking the drugs

Novo Nordisk has announced the U.S

The identified challenges underscore the need for supportive clinical and population policies that equitably address food and nutrition insecurity to support effective, cost-effective, and equitable use of GLP-1s